Estes Bright Lori M, Mondal Arnab, Pinon Vicente, Kumar Anil, Thompson Stephen, Brisbois Elizabeth J, Handa Hitesh
School of Chemical, Materials, and Biomedical Engineering, College of Engineering, University of Georgia, Athens, GA, 30602, USA.
Pharmaceutical and Biomedical Sciences Department, College of Pharmacy, University of Georgia, Athens, GA, 30602, USA.
Nitric Oxide. 2025 Feb;154:19-28. doi: 10.1016/j.niox.2024.11.003. Epub 2024 Nov 17.
The persistent infection of medical devices by opportunistic pathogens has led to the development of antimicrobial medical device polymers. Nitric oxide (NO) is an endogenous antimicrobial molecule that is released through the degradation of synthetic donor molecules such as S-nitroso-N-acetylpenicillamine (SNAP) embedded into polymer membranes. It is hypothesized that the clinical success of these polymers is enhanced by the physiological release of NO and the consequent prevention of infection. However, such NO-releasing materials have never been evaluated against microbial loads that are commensurate with clinical infection levels. This study aimed to develop a standardized polymer film impregnated with SNAP that consistently releases NO and evaluates its efficacy against bacterial loads that represent clinical infection parameters. Microbial loads of 10, 10, and 10 (colony-forming units) CFU mL were exposed to the NO-releasing polymer, corresponding to bloodstream infections, catheter-associated urinary tract infections, and standard laboratory exposure levels that have been reported in the scientific literature. By 24 h, SNAP films led to >1 log reduction of adhered and viable E. coli at all tested microbial loads compared to control polydimethylsiloxane (PDMS). Further, SNAP films displayed no viable adhered S. aureus at the 10 microbial level for the entire study and showed total planktonic killing by 8 h. NO localization within bacterial cells adhering to the films was evaluated, revealing higher NO uptake and consequent bacterial killing by SNAP samples. This unique study shows that NO-releasing polymers not only kill bacteria adhered to the polymer surface, but localized delivery leads to environmental planktonic bacterial killing that prevents adhesion from occurring. Furthermore, the promising findings of NO-releasing polymers in scientific research indicate their potential for successful application in clinical settings to prevent infections.
机会性病原体对医疗器械的持续感染促使了抗菌医疗器械聚合物的发展。一氧化氮(NO)是一种内源性抗菌分子,它通过嵌入聚合物膜中的合成供体分子(如S-亚硝基-N-乙酰青霉胺(SNAP))的降解而释放。据推测,这些聚合物的临床成功得益于NO的生理性释放以及随之而来的感染预防。然而,此类释放NO的材料从未针对与临床感染水平相当的微生物负荷进行过评估。本研究旨在开发一种浸渍有SNAP的标准化聚合物薄膜,该薄膜能持续释放NO,并评估其对代表临床感染参数的细菌负荷的疗效。将10⁵、10⁶和10⁷(菌落形成单位)CFU/mL的微生物负荷暴露于释放NO的聚合物中,分别对应血流感染、导管相关尿路感染以及科学文献中报道的标准实验室暴露水平。到24小时时,与对照聚二甲基硅氧烷(PDMS)相比,SNAP薄膜在所有测试的微生物负荷下均使粘附并存活的大肠杆菌减少了>1个对数级。此外,在整个研究过程中,SNAP薄膜在10⁷微生物水平下未检测到存活的粘附金黄色葡萄球菌,并且在8小时时显示出对浮游细菌的完全杀灭。对粘附在薄膜上的细菌细胞内的NO定位进行了评估,结果显示SNAP样品对NO的摄取更高,从而导致细菌杀灭。这项独特的研究表明,释放NO的聚合物不仅能杀死粘附在聚合物表面的细菌,而且局部递送会导致环境中浮游细菌的杀灭,从而防止粘附的发生。此外,释放NO的聚合物在科学研究中的有前景的发现表明它们在临床环境中预防感染的成功应用潜力。